Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Alpelisib × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 30 OTHER 23 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Genetic Diseases, Inborn 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 38 Docetaxel 30 Paclitaxel 28 Tamoxifen 26 Doxorubicin 25 Trastuzumab 24 Radiotherapy 19 Letrozole 14 Epirubicin 14 Fluorouracil 10 Immunohistochemistry 9 Capecitabine 9 exemestane 8 Lapatinib 8 Bevacizumab 8 Anastrozole 8 Methotrexate 7 Gene Expression Profiling 7 Filgrastim 7 palbociclib 6 Zoledronic Acid 6 Surgical Procedures, Operative 6 Microarray Analysis 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Chemotherapy, Adjuvant 6 Carboplatin 6 Amplified Fragment Length Polymorphism Analysis 6 pertuzumab 5 Taxes 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05392608 2025-09-17

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡